Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Repeat Dose Study Of The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

NCT00442221 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT00442221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Repeat Dose Study Of The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
Lead sponsor
POZEN
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
August 31, 2004
Enrollment
500
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headaches